Add like
Add dislike
Add to saved papers

Composite Cardiovascular Risk Factor Target Achievement and its Predictors in US Adults with Diabetes: The Diabetes Collaborative Registry.

BACKGROUND AND OBJECTIVE: Patients with diabetes mellitus (DM) at composite atherosclerotic cardiovascular disease (ASCVD) risk factor (RF) targets have >50% lower ASCVD risks. Limited "real world" data exists on how often such targets are reached. We studied multiple RF target attainment for ASCVD prevention and its predictors in a contemporary DM registry.

METHODS: In the US Diabetes Collaborative Registry we identified patients at target for HbA1c (<7.0% or <8.0% if with ASCVD), LDL-C (<100 or <70 mg/dl if ASCVD), blood pressure (<140/90 mmHg and <130/80 mmHg as an alternate), and nonsmoking status by sex, race, and history of ASCVD. Multiple logistic regression examined predictors of target attainment.

RESULTS: In 74,393 DM persons with available data (mean age 69.0 years, 41.0% female), overall target attainment for HbA1c, BP, LDL-C and non-smoking status was 73.6%, 69.0% (40.3% if BP<130/80 mmHg), 48.6% and 85.2%, respectively. Only 21.6% (13.0% with BP<130/80 mmHg) were at target for all four measures, being greater in men (23.6%) versus women (18.6%) and in whites (22.5%) compared to African-Americans (14.7%) and other races (20.8%) (p<0.01). 62.4% were on a moderate/high intensity statin. Age (>65: odds ratio, OR=1.9 [1.7-2.0] or 55-64: OR=1.3 [1.2-1.4] vs. <55 years), male sex (OR=1.3 [1.3-1.4]), white race (OR=1.4 [1.3-1.5]), middle or high income (OR's 1.1 [1.1-1.2] and 1.4 [1.4-1.5], respectively) were associated, and depression (OR=0.9 [0.8-1.0]) was inversely associated with meeting all 4 targets (all p=0.01 to p<0.001).

CONCLUSIONS: In our US registry of DM patients, only 1 in 5 are achieving comprehensive RF control. Multifactorial interventions will be necessary to optimize ASCVD RF control. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app